News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
220,659 Results
Type
Article (10332)
Company Profile (40)
Press Release (210287)
Section
Business (58847)
Career Advice (448)
Deals (10350)
Drug Delivery (19)
Drug Development (25538)
Employer Resources (43)
FDA (6914)
Job Trends (5114)
News (104023)
Policy (10355)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 Pharm Country Standard (1)
Academia (936)
Adcomms (9)
Allergies (22)
Alliances (18418)
ALS (32)
Alzheimer's disease (423)
Antibody-drug conjugate (ADC) (36)
Approvals (6935)
Artificial intelligence (121)
Autoimmune disease (1)
Automation (5)
Bankruptcy (76)
Best Places to Work (4672)
BIOSECURE Act (2)
Biosimilars (18)
Biotechnology (25)
Bladder cancer (33)
Brain cancer (19)
Breast cancer (134)
Cancer (965)
Cardiovascular disease (55)
Career advice (393)
Career pathing (3)
CAR-T (46)
Cell therapy (120)
Cervical cancer (9)
Clinical research (21608)
Collaboration (293)
Compensation (62)
Complete response letters (2)
COVID-19 (964)
CRISPR (8)
C-suite (46)
Cystic fibrosis (27)
Data (759)
Decentralized trials (1)
Denatured (1)
Depression (14)
Diabetes (72)
Diagnostics (6035)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (36)
Drug pricing (12)
Drug shortages (2)
Duchenne muscular dystrophy (25)
Earnings (22068)
Editorial (3)
Employer branding (5)
Employer resources (40)
Events (29247)
Executive appointments (197)
FDA (7369)
Featured Employer (9)
Fibrodysplasia Ossificans Progressiva (1)
Funding (234)
Gene editing (20)
Generative AI (12)
Gene therapy (68)
GLP-1 (150)
Government (1387)
Grass and pollen (1)
Guidances (16)
Healthcare (7049)
Huntington's disease (2)
IgA nephropathy (4)
Immunology and inflammation (18)
Indications (11)
Infectious disease (1010)
Inflammatory bowel disease (35)
Inflation Reduction Act (2)
Influenza (20)
Intellectual property (15)
Interviews (73)
IPO (4484)
IRA (3)
Job creations (661)
Job search strategy (327)
Kidney cancer (5)
Labor market (3)
Layoffs (61)
Leadership (4)
Legal (1381)
Liver cancer (37)
Lung cancer (147)
Lymphoma (77)
Management (17)
Manufacturing (88)
MASH (10)
Medical device (5663)
Medtech (5665)
Mergers & acquisitions (6069)
Metabolic disorders (140)
Multiple sclerosis (18)
NASH (7)
Neurodegenerative disease (23)
Neuropsychiatric disorders (8)
Neuroscience (559)
NextGen: Class of 2025 (1867)
Non-profit (1422)
Northern California (864)
Now hiring (2)
Obesity (59)
Opinion (70)
Ovarian cancer (34)
Pain (15)
Pancreatic cancer (33)
Parkinson's disease (32)
Partnered (8)
Patents (47)
Patient recruitment (34)
Peanut (8)
People (15289)
Pharmaceutical (9)
Pharmacy benefit managers (1)
Phase I (6107)
Phase II (9390)
Phase III (8083)
Pipeline (313)
Podcasts (2)
Policy (9)
Postmarket research (813)
Preclinical (1941)
Press Release (17)
Prostate cancer (51)
Psychedelics (10)
Radiopharmaceuticals (153)
Rare diseases (87)
Real estate (1696)
Recruiting (17)
Regulatory (8322)
Reports (16)
Research institute (943)
Resumes & cover letters (68)
Rett syndrome (1)
RSV (3)
Schizophrenia (13)
Series A (42)
Series B (30)
Service/supplier (3)
Sickle cell disease (7)
Southern California (662)
Special edition (2)
Sponsored (12)
Startups (1042)
State (2)
Stomach cancer (4)
Supply chain (16)
The Weekly (1)
United States (7048)
Vaccines (151)
Venture capitalists (11)
Webinars (2)
Weight loss (30)
Women's health (11)
Worklife (1)
Date
Today (63)
Last 7 days (298)
Last 30 days (1167)
Last 365 days (13308)
2025 (2241)
2024 (13379)
2023 (14695)
2022 (19443)
2021 (19676)
2020 (18890)
2019 (15674)
2018 (12019)
2017 (11286)
2016 (10726)
2015 (12322)
2014 (8739)
2013 (7489)
2012 (8064)
2011 (8406)
2010 (7287)
Location
Africa (241)
Alabama (22)
Alaska (3)
Arizona (75)
Arkansas (3)
Asia (12981)
Australia (2465)
California (1869)
Canada (597)
China (163)
Colorado (115)
Connecticut (96)
Delaware (51)
Europe (31423)
Florida (266)
Georgia (57)
Idaho (17)
Illinois (178)
India (8)
Indiana (88)
Iowa (3)
Japan (48)
Kansas (35)
Kentucky (12)
Louisiana (1)
Maine (29)
Maryland (224)
Massachusetts (1249)
Michigan (78)
Minnesota (136)
Mississippi (1)
Missouri (35)
Montana (9)
Nebraska (12)
Nevada (13)
New Hampshire (38)
New Jersey (568)
New Mexico (18)
New York (559)
North Carolina (360)
North Dakota (8)
Northern California (864)
Ohio (54)
Oklahoma (6)
Oregon (11)
Pennsylvania (302)
Puerto Rico (2)
Rhode Island (10)
South America (327)
South Carolina (3)
Southern California (662)
Tennessee (41)
Texas (257)
Utah (96)
Virginia (56)
Washington D.C. (17)
Washington State (138)
West Virginia (1)
Wisconsin (31)
220,659 Results for "gold standard diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of metastatic colorectal cancer.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sysmex Inostics Achieves CAP Accreditation and ISO 15189 Certification, Enhancing Quality Standards in Diagnostic Excellence
December 11, 2024
·
2 min read
Deals
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic’s Proposed Merger with Standard BioTools
Dr. Larry Gold, the founder of SomaLogic, Inc. and Dr. Jason Cleveland, SomaLogic’s current Chief Technology Officer, are issuing the below letter to SomaLogic’s stockholders regarding their opposition to the Company’s proposed merger with Standard BioTools, Inc. .
December 28, 2023
·
5 min read
Press Releases
NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment
January 24, 2025
·
4 min read
Press Releases
Standard BioTools to Participate in Upcoming March 2025 Investor Conferences
February 28, 2025
·
1 min read
Press Releases
New Investment from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Leads Efforts to Develop Standardization Materials for Leading Diagnostic Biomarker
November 15, 2024
·
5 min read
BioCapital
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
QIAGEN announced that it welcomes new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis infection with modern blood-based tests such as QIAGEN’s market-leading QuantiFERON-TB Gold Plus.
June 27, 2024
·
7 min read
Gold Colloid Co. and Hangzhou Clongene Biotech Enter Strategic Agreement to Bring Rapid In-Vitro Diagnostics and Raw Materials to the US Market
Gold Colloid Co., a leading distributor of medical and diagnostic products in the United States, announced today a strategic partnership with Hangzhou Clongene Biotech Co., Ltd., a renowned Chinese manufacturer of in-vitro diagnostic (IVD) rapid tests and raw materials.
January 12, 2024
·
2 min read
Press Releases
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
December 13, 2024
·
27 min read
Press Releases
Gold Biotechnology Enhances Visibility and Engagement Through Bioz Partnership
November 26, 2024
·
3 min read
1 of 22,066
Next
